argatroban
HIT Guidelines:
Heparin induced thrombocytopenia (HIT) detection and management: See Guideline 916.5002
Argatroban dosing in patients with HIT (Heparin induced thrombocytopenia): See Protocol 916.6010
Reversal Guidelines:
For reversal, turn off the infusion (short half-life): See Reversal Guideline 900.5010
Reversal of heparin in Pediatrics: See Reversal Guideline 900.5866
Other Guidelines:
LH Anticoagulant Management: Policy 900.3207
Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681
HIT Guidelines:
Heparin induced thrombocytopenia (HIT) detection and management: See Guideline 916.5002
Argatroban dosing in patients with HIT (Heparin induced thrombocytopenia): See Protocol 916.6010
Reversal Guidelines:
For reversal, turn off the infusion (short half-life): See Reversal Guideline 900.5010
Reversal of heparin in Pediatrics: See Reversal Guideline 900.5866
Other Guidelines:
LH Anticoagulant Management: Policy 900.3207
Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5681